Leidos Holdings, Inc. Stock News

It's not always fun being right -- especially when you write about defense stocks, and you have to tell people that defense stocks are too expensive to invest in right now.

Leidos Holdings (LDOS 4.35%) reported better-than-expected quarterly results this morning, helping ease concerns that efforts by the task forced called the Department of Government Efficiency (DOGE) would eat into earnings. Investors cheered the results, sending Leidos shares up 4% around 2 p.m.

Leidos Holdings, Inc. (NYSE:LDOS ) Q1 2025 Earnings Call May 6, 2025 8:00 AM ET Company Participants Stuart Davis - IR Tom Bell - CEO Chris Cage - CFO Conference Call Participants Peter Arment - Robert W. Baird Joshua Korn - Barclays Bank Sheila Kahyaoglu - Jefferies Colin Canfield - Cantor Fitzgerald Mariana Mora - Bank of America Securities Jason Gursky - Citigroup Inc. Tyler Barishaw - Scott...

Revenues of $4.2 billion, up 7% year-over-year Net income of $365 million or $2.77 per diluted share Adjusted EBITDA (non-GAAP) of $601 million (14.2% margin) Non-GAAP Diluted Earnings per Share of $2.97, up 30% year-over-year Cash Flows from Operations of $58 million; Free Cash Flow (non-GAAP) of $36 million RESTON, Va. , May 6, 2025 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE: LDOS) today rep...

RESTON, Va. , May 5, 2025 /PRNewswire/ -- Leidos (NYSE:LDOS) will modernize and operate information technology systems for the Defense Threat Reduction Agency (DTRA) enterprise that will help the agency deter, prevent and prevail against emerging threats around the world.

RESTON, Va. , May 2, 2025 /PRNewswire/ -- Leidos Holdings, Inc. (NYSE:LDOS) announced today that its board of directors has declared a quarterly cash dividend of $0.40 per outstanding share of the company's common stock.

SEATTLE & RESTON, Va.--(BUSINESS WIRE)-- #AIsecurity--Leidos and Protect AI to deliver full lifecycle security capabilities across the entire AI supply chain for U.S. government agencies.

RESTON, Va. , April 18, 2025 /PRNewswire/ -- Leidos (NYSE: LDOS) is committing $10 million to accelerate the use of artificial intelligence for detecting and managing diseases, in collaboration with the University of Pittsburgh's Computational Pathology and AI Center of Excellence (CPACE).